Navigation Links
Registration now open for StemCONN 2013 stem cell symposium April 3, 2013 in New Haven, CT
Date:12/4/2012

NEW HAVEN, Conn., Dec. 4, 2012 /PRNewswire-iReach/ -- Registration is now open for StemCONN 2013.

The full-day scientific symposium, with the theme Realizing the Promise, will take place Wednesday, April 3, in New Haven, CT at the Omni New Haven Hotel at Yale. StemCONN 2013 will feature international leaders in stem cell research and biotechnology and provide a forum for education, exploration, and discussion of stem cells and their clinical applications, now and in the future.

To register, and for more details, visit the official website at http://stemconn.org/.

In addition to the scientific symposia, StemCONN will include a poster session at which academic research entities both within and outside of Connecticut are invited to share their work. Poster session deadline: January 20, 2013. See the website for instructions on submitting abstracts.

Featured speakers include: Larry Goldsetin, Ph.D., Professor at University of California San Diego and Director of the UC San Diego Stem Cell Program; Edison Liu, M.D., President and CEO of Jackson Laboratories and President of the Human Genome Organization (HUGO); Jonathan Rothberg, Ph.D., Founder and CEO of five Connecticut  biotechnology and genomic companies (Ion Torrent Systems, RainDance Technologies; Clarifi; 454 Life Sciences; CureGen Corporation); and David T. Scadden, M.D., Director, MGH Center for Regenerative Medicine and Co-Director of Harvard Stem Cell Center.

Sponsorships and exhibitor space are available.

The organizers of StemConn 2013 are CURE (Connecticut United for Research Excellence), the Connecticut Department of Public Health, the University of Connecticut Stem Cell Institute, Wesleyan University, and the Yale Stem Cell Center.

Media Contact:

Bill Kelly HarveyMalis Communications LLC, 203-375-2696, bill@harveymalis.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE HarveyMalis Communications LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pennsylvania DEP Announces X-ray Registration Fee Amnesty Program
2. Sihuans First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
3. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
4. PatientPay from Zepherella Makes Patient Registration and Payment Pre-Authorization Faster, Easier for Physician Groups
5. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
6. Intercept Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
7. Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
8. MEK162 Registration Path Announced
9. STD Med Inc. Receives ANVISA Registration for Class III Medical Devices in Brazil
10. IntelliCell BioSciences Announces FDA Registration for its Cell Processing Facility
11. Medical Marijuana Inc. Portfolio Company CanChew BioTechnologies Inc. Announces Final Three Days for Market Survey and Free Product Trial Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):